{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:29:12Z","timestamp":1790998152670,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People\u2019s Republic of China","doi-asserted-by":"crossref","award":["2022YFC2304900"],"award-info":[{"award-number":["2022YFC2304900"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People\u2019s Republic of China","doi-asserted-by":"crossref","award":["2022YFC2505100"],"award-info":[{"award-number":["2022YFC2505100"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2022YFC2505103"],"award-info":[{"award-number":["2022YFC2505103"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Outstanding Young Scholars Support Program","award":["3111500001"],"award-info":[{"award-number":["3111500001"]}]},{"name":"Epidemiology modeling and risk assessment","award":["20200344"],"award-info":[{"award-number":["20200344"]}]},{"name":"Xi\u2019an Jiaotong University Young Scholar Support Grant","award":["YX6J004"],"award-info":[{"award-number":["YX6J004"]}]},{"name":"the Postdoctoral Fellowship Program of CPSF","award":["GZB20230567"],"award-info":[{"award-number":["GZB20230567"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404345"],"award-info":[{"award-number":["82404345"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["glob health res policy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although liver cancer has varied causes, its evolving epidemiology and causal drivers remain underexplored. This study quantifies the trends and drivers of liver cancer burden attributable to specific causes from 1990 to 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using data from the Global Burden of Disease Study, we extracted prevalence, mortality, and disability-adjusted life years (DALYs) associated with specific causes of\u00a0liver cancer. We assessed spatio-temporal trends across the sociodemographic index (SDI) and quantified the contributions of epidemiological shifts, population growth, and ageing to DALYs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In 2021, liver cancer accounted for 0.74 million cases, 0.48 million deaths, and 12.89 million DALYs globally. Average annual percentage changes (AAPCs) in prevalence, mortality, and DALY rates from 1990 to 2021 were 1.17%, 1.04%, and 0.48%, respectively. HBV, HCV, and alcohol use were major contributors to DALYs, accounting for 1.92 million (36.00%), 1.53 million (28.62%), and 1.27 million (23.88%) of the increase, respectively. High-income North America and Western Europe experienced rapid growth in liver cancer prevalence from 1990 to 2021, while High-income North America and Southern Latin America had rapid growth in mortality. Global DALY increases were mainly driven by population growth (3.91 million, 73.29%) and population ageing (3.03 million, 56.86%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The study revealed that hepatitis B, hepatitis C, and alcohol consumption were the primary contributors to the increasing DALYs from liver cancer, with population growth and ageing as key drivers of these\u00a0changes. These findings underscore the importance of considering the major factors and demographic dynamics in addressing the burden of liver cancer when formulating prevention and intervention strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41256-025-00416-y","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T06:00:19Z","timestamp":1747720819000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The spatio-temporal trends and determinants of liver cancer attributable to specific etiologies: a systematic analysis from the Global Burden of Disease Study 2021"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4220-842X","authenticated-orcid":false,"given":"Jinli","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1463-8035","authenticated-orcid":false,"given":"Fanpu","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2343-084X","authenticated-orcid":false,"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"key":"416_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA: Cancer J Clin"},{"key":"416_CR2","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.jhep.2018.12.001","volume":"70","author":"Z Liu","year":"2019","unstructured":"Liu Z, Jiang Y, Yuan H, Fang Q, Cai N, Suo C, Jin L, et al. The trends in incidence of primary liver cancer caused by specific etiologies: results from the global burden of disease study 2016 and implications for liver cancer prevention. J Hepatol. 2019;70:674\u201383.","journal-title":"J Hepatol"},{"key":"416_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.cld.2015.01.001","volume":"19","author":"KA McGlynn","year":"2015","unstructured":"McGlynn KA, Petrick JL, London WT. Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. Clin Liver Dis. 2015;19:223\u201338.","journal-title":"Clin Liver Dis"},{"key":"416_CR4","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/hep.29498","volume":"67","author":"PC Valery","year":"2018","unstructured":"Valery PC, Laversanne M, Clark PJ, Petrick JL, McGlynn KA, Bray F. Projections of primary liver cancer to 2030 in 30 countries worldwide. Hepatology (Baltimore, MD). 2018;67:600\u201311.","journal-title":"Hepatology (Baltimore, MD)"},{"key":"416_CR5","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3350\/cmh.2022.0316","volume":"29","author":"S Choi","year":"2023","unstructured":"Choi S, Kim BK, Yon DK, Lee SW, Lee HG, Chang HH, Park S, et al. Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990\u20132019: A DALY-based analysis of the global burden of disease 2019 study. Clin Mol Hepatol. 2023;29:433\u201352.","journal-title":"Clin Mol Hepatol"},{"key":"416_CR6","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","volume":"77","author":"H Rumgay","year":"2022","unstructured":"Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, Laversanne M, et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77:1598\u2013606.","journal-title":"J Hepatol"},{"key":"416_CR7","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16:589\u2013604.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"416_CR8","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1038\/ajg.2015.289","volume":"110","author":"JD Yang","year":"2015","unstructured":"Yang JD, Gyedu A, Afihene MY, Duduyemi BM, Micah E, Kingham TP, Nyirenda M, et al. Hepatocellular carcinoma occurs at an earlier age in Africans, particularly in association with chronic hepatitis B. Am J Gastroenterol. 2015;110:1629\u201331.","journal-title":"Am J Gastroenterol"},{"key":"416_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S2468-1253(16)30161-3","volume":"2","author":"JD Yang","year":"2017","unstructured":"Yang JD, Mohamed EA, Aziz AOA, Shousha HI, Hashem MB, Nabeel MM, Abdelmaksoud AH, et al. Characteristics, management, and outcomes of patients with hepatocellular carcinoma in Africa: a multicountry observational study from the Africa liver cancer consortium. Lancet Gastroenterol Hepatol. 2017;2:103\u201311.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"416_CR10","unstructured":"World Health Organization. Global status report on alcohol and health and treatment of substance use disorders 2018. WHO https:\/\/www.who.int\/publications\/i\/item\/9789240096745 (2024)."},{"key":"416_CR11","doi-asserted-by":"publisher","first-page":"5335","DOI":"10.3390\/nu14245335","volume":"14","author":"W Guo","year":"2022","unstructured":"Guo W, Ge X, Lu J, Xu X, Gao J, Wang Q, Song C, et al. Diet and risk of non-alcoholic fatty liver disease, cirrhosis, and liver cancer: a large prospective cohort study in UK biobank. Nutrients. 2022;14:5335.","journal-title":"Nutrients"},{"key":"416_CR12","unstructured":"World Health Organization. (2020). World cancer report: cancer research for cancer prevention. https:\/\/www.iarc.who.int\/featured-news\/new-world-cancer-report\/."},{"key":"416_CR13","unstructured":"World Health Organization-International Agency for Research on Cancer. World cancer report. https:\/\/www.iarc.who.int\/cards_page\/world-cancer-report\/."},{"key":"416_CR14","unstructured":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet (London, England) 2024;403:2133\u20132161."},{"key":"416_CR15","unstructured":"Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Lancet (London, England) 2024;403:2162\u20132203."},{"key":"416_CR16","first-page":"34","volume":"2022","author":"DQ Huang","year":"2010","unstructured":"Huang DQ, Singal AG, Kono Y, Tan DJH, El-Serag HB, Loomba R. Changing global epidemiology of liver cancer from to 2019: NASH is the fastest growing cause of liver cancer. Cell Metab. 2010;2022:34.","journal-title":"Cell Metab"},{"key":"416_CR17","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41575-023-00760-9","volume":"20","author":"Y-C Hsu","year":"2023","unstructured":"Hsu Y-C, Huang DQ, Nguyen MH. Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nat Rev Gastroenterol Hepatol. 2023;20:524\u201337.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"416_CR18","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0140-6736(23)01320-X","volume":"402","author":"M Martinello","year":"2023","unstructured":"Martinello M, Solomon SS, Terrault NA, Dore GJ. Hepatitis C. Lancet (London, England). 2023;402:1085\u201396.","journal-title":"Lancet (London, England)"},{"key":"416_CR19","unstructured":"WHO Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022\u20132030. World Health Organization, Geneva2022."},{"key":"416_CR20","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/S1470-2045(21)00279-5","volume":"22","author":"H Rumgay","year":"2021","unstructured":"Rumgay H, Shield K, Charvat H, Ferrari P, Sornpaisarn B, Obot I, Islami F, et al. Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study. Lancet Oncol. 2021;22:1071\u201380.","journal-title":"Lancet Oncol"},{"key":"416_CR21","unstructured":"Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the global burden of disease study 2020. Lancet (London, England) 2022;400: 185\u2013235"},{"key":"416_CR22","doi-asserted-by":"publisher","first-page":"djv341","DOI":"10.1093\/jnci\/djv341","volume":"108","author":"W-C Pan","year":"2016","unstructured":"Pan W-C, Wu C-D, Chen M-J, Huang Y-T, Chen C-J, Su H-J, Yang H-I. Fine particle pollution, alanine transaminase, and liver cancer: a Taiwanese prospective cohort study (REVEAL-HBV). J National Cancer Instit. 2016;108:djv341.","journal-title":"J National Cancer Instit"},{"key":"416_CR23","doi-asserted-by":"publisher","first-page":"e140","DOI":"10.1016\/S2468-2667(19)30248-8","volume":"5","author":"M Kivim\u00e4ki","year":"2020","unstructured":"Kivim\u00e4ki M, Batty GD, Pentti J, Shipley MJ, Sipil\u00e4 PN, Nyberg ST, Suominen SB, et al. Association between socioeconomic status and the development of mental and physical health conditions in adulthood: a multi-cohort study. The Lancet Public Health. 2020;5:e140\u20139.","journal-title":"The Lancet Public Health"},{"key":"416_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.smrv.2017.11.001","volume":"40","author":"X Tan","year":"2018","unstructured":"Tan X, Chapman CD, Cedernaes J, Benedict C. Association between long sleep duration and increased risk of obesity and type 2 diabetes: a review of possible mechanisms. Sleep Med Rev. 2018;40:127\u201334.","journal-title":"Sleep Med Rev"},{"key":"416_CR25","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1038\/s41380-019-0595-x","volume":"25","author":"Y-H Wang","year":"2020","unstructured":"Wang Y-H, Li J-Q, Shi J-F, Que J-Y, Liu J-J, Lappin JM, Leung J, et al. Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies. Mol Psychiatry. 2020;25:1487\u201399.","journal-title":"Mol Psychiatry"},{"key":"416_CR26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3350\/cmh.2020.0176","volume":"27","author":"W Sohn","year":"2021","unstructured":"Sohn W, Lee HW, Lee S, Lim JH, Lee MW, Park CH, Yoon SK. Obesity and the risk of primary liver cancer: a systematic review and meta-analysis. Clin Mol Hepatol. 2021;27:157\u201374.","journal-title":"Clin Mol Hepatol"},{"key":"416_CR27","first-page":"305","volume":"22","author":"MC Kew","year":"2013","unstructured":"Kew MC. Aflatoxins as a cause of hepatocellular carcinoma. J Gastrointestinal Liver Diseases\u202f: JGLD. 2013;22:305\u201310.","journal-title":"J Gastrointestinal Liver Diseases : JGLD"},{"key":"416_CR28","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1093\/carcin\/17.6.1317","volume":"17","author":"Y Ueno","year":"1996","unstructured":"Ueno Y, Nagata S, Tsutsumi T, Hasegawa A, Watanabe MF, Park HD, Chen GC, et al. Detection of microcystins, a blue-green algal hepatotoxin, in drinking water sampled in Haimen and Fusui, endemic areas of primary liver cancer in China, by highly sensitive immunoassay. Carcinogenesis. 1996;17:1317\u201321.","journal-title":"Carcinogenesis"},{"key":"416_CR29","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S0140-6736(11)60448-0","volume":"377","author":"T Alcorn","year":"2011","unstructured":"Alcorn T. Mongolia\u2019s struggle with liver cancer. Lancet (London, England). 2011;377:1139\u201340.","journal-title":"Lancet (London, England)"},{"key":"416_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/CEJ.0b013e32833f0c8e","volume":"20","author":"B Dondog","year":"2011","unstructured":"Dondog B, Lise M, Dondov O, Baldandorj B, Franceschi S. Hepatitis B and C virus infections in hepatocellular carcinoma and cirrhosis in Mongolia. Euro J Cancer Prev: Off J Euro Cancer Prev Org (ECP). 2011;20:33\u20139.","journal-title":"Euro J Cancer Prev: Off J Euro Cancer Prev Org (ECP)"},{"key":"416_CR31","volume-title":"Viral hepatitis in Mongolia: situation and response","author":"WHO Regional Office for the Western Pacific","year":"2015","unstructured":"WHO Regional Office for the Western Pacific. Viral hepatitis in Mongolia: situation and response. Manila: World Health Organization Regional Office for the Western Pacific; 2015."},{"key":"416_CR32","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1017\/S0007114520001208","volume":"124","author":"W-S Yang","year":"2020","unstructured":"Yang W-S, Zeng X-F, Liu Z-N, Zhao Q-H, Tan Y-T, Gao J, Li H-L, et al. Diet and liver cancer risk: a narrative review of epidemiological evidence. Br J Nutr. 2020;124:330\u201340.","journal-title":"Br J Nutr"},{"key":"416_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41575-022-00688-6","volume":"20","author":"DQ Huang","year":"2023","unstructured":"Huang DQ, Mathurin P, Cortez-Pinto H, Loomba R. Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors. Nat Rev Gastroenterol Hepatol. 2023;20:37\u201349.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"416_CR34","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2023.02.034","volume":"79","author":"R Barouki","year":"2023","unstructured":"Barouki R, Samson M, Blanc EB, Colombo M, Zucman-Rossi J, Lazaridis KN, Miller GW, et al. The exposome and liver disease - how environmental factors affect liver health. J Hepatol. 2023;79:492\u2013505.","journal-title":"J Hepatol"},{"key":"416_CR35","doi-asserted-by":"publisher","first-page":"799","DOI":"10.4093\/dmj.2021.0077","volume":"45","author":"D-S Kim","year":"2021","unstructured":"Kim D-S, Scherer PE. Obesity, diabetes, and increased cancer progression. Diabetes Metab J. 2021;45:799\u2013812.","journal-title":"Diabetes Metab J"},{"key":"416_CR36","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.3390\/ijms22042163","volume":"22","author":"Y Rajesh","year":"2021","unstructured":"Rajesh Y, Sarkar D. Association of adipose tissue and adipokines with development of obesity-induced liver cancer. Int J Mol Sci. 2021;22:2163.","journal-title":"Int J Mol Sci"},{"key":"416_CR37","doi-asserted-by":"publisher","first-page":"1166440","DOI":"10.3389\/fimmu.2023.1166440","volume":"14","author":"J Yang","year":"2023","unstructured":"Yang J, He J, Feng Y, Xiang M. Obesity contributes to hepatocellular carcinoma development via immunosuppressive microenvironment remodeling. Front Immunol. 2023;14:1166440.","journal-title":"Front Immunol"},{"key":"416_CR38","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/cac2.12025","volume":"40","author":"M Cao","year":"2020","unstructured":"Cao M, Li H, Sun D, Chen W. Cancer burden of major cancers in China: a need for sustainable actions. Cancer Commun (London, England). 2020;40:205\u201310.","journal-title":"Cancer Commun (London, England)"},{"key":"416_CR39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ejca.2018.02.010","volume":"94","author":"Y-J Chu","year":"2018","unstructured":"Chu Y-J, Yang H-I, Wu H-C, Lee M-H, Liu J, Wang L-Y, Lu S-N, et al. Aflatoxin B1 exposure increases the risk of hepatocellular carcinoma associated with hepatitis C virus infection or alcohol consumption. Euro J Cancer (Oxford, England: 1990). 2018;94:37\u201346.","journal-title":"Euro J Cancer (Oxford, England: 1990)"},{"key":"416_CR40","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","volume":"400","author":"A Vogel","year":"2022","unstructured":"Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet (London, England). 2022;400:1345\u201362.","journal-title":"Lancet (London, England)"},{"key":"416_CR41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1614362","volume":"377","author":"A Afshin","year":"2017","unstructured":"Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, Lee A, Marczak L, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377:13\u201327.","journal-title":"N Engl J Med"},{"key":"416_CR42","unstructured":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet (London, England) 2023; 402:203\u2013234."},{"key":"416_CR43","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s00125-022-05713-6","volume":"65","author":"J Liu","year":"2022","unstructured":"Liu J, Bai R, Chai Z, Cooper ME, Zimmet PZ, Zhang L. Low- and middle-income countries demonstrate rapid growth of type 2 diabetes: an analysis based on global burden of disease 1990\u20132019 data. Diabetologia. 2022;65:1339.","journal-title":"Diabetologia"},{"key":"416_CR44","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.ccell.2023.05.010","volume":"41","author":"M Rask-Andersen","year":"2023","unstructured":"Rask-Andersen M, Ivansson E, H\u00f6glund J, Ek WE, Karlsson T, Johansson \u00c5. Adiposity and sex-specific cancer risk. Cancer Cell. 2023;41:1186.","journal-title":"Cancer Cell"},{"key":"416_CR45","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3350\/cmh.2021.0383","volume":"28","author":"HS Shin","year":"2022","unstructured":"Shin HS, Jun BG, Yi S-W. Impact of diabetes, obesity, and dyslipidemia on the risk of hepatocellular carcinoma in patients with chronic liver diseases. Clin Mol Hepatol. 2022;28:773\u201389.","journal-title":"Clin Mol Hepatol"},{"key":"416_CR46","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1186\/s12889-020-09502-x","volume":"20","author":"J Liu","year":"2020","unstructured":"Liu J, Ren Z-H, Qiang H, Wu J, Shen M, Zhang L, Lyu J. Trends in the incidence of diabetes mellitus: results from the global burden of disease study 2017 and implications for diabetes mellitus prevention. BMC Public Health. 2020;20:1415.","journal-title":"BMC Public Health"},{"key":"416_CR47","unstructured":"Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the global burden of disease study 2019. Lancet (London, England) 2020; 396:1160-1203."},{"key":"416_CR48","unstructured":"Global fertility in 204 countries and territories, 1950\u20132021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. Lancet (London, England) 2024."},{"key":"416_CR49","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1146\/annurev-soc-060116-053442","volume":"43","author":"B Zaidi","year":"2017","unstructured":"Zaidi B, Morgan SP. The second demographic transition theory: a review and appraisal. Ann Rev Sociol. 2017;43:473\u201392.","journal-title":"Ann Rev Sociol"},{"key":"416_CR50","doi-asserted-by":"publisher","first-page":"a021410","DOI":"10.1101\/cshperspect.a021410","volume":"5","author":"JH MacLachlan","year":"2015","unstructured":"MacLachlan JH, Cowie BC. Hepatitis B virus epidemiology. Cold Spring Harb Perspect Med. 2015;5:a021410.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"416_CR51","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/S2468-1253(17)30295-9","volume":"2","author":"CW Spearman","year":"2017","unstructured":"Spearman CW, Afihene M, Ally R, Apica B, Awuku Y, Cunha L, Dusheiko G, et al. Hepatitis B in sub-b Saharan Africa: strategies to achieve the 2030 elimination targets. Lancet Gastroenterol Hepatol. 2017;2:900\u20139.","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Global Health Research and Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41256-025-00416-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41256-025-00416-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41256-025-00416-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T15:27:12Z","timestamp":1768404432000},"score":1,"resource":{"primary":{"URL":"https:\/\/ghrp.biomedcentral.com\/articles\/10.1186\/s41256-025-00416-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["416"],"URL":"https:\/\/doi.org\/10.1186\/s41256-025-00416-y","relation":{},"ISSN":["2397-0642"],"issn-type":[{"value":"2397-0642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"9 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No human or animal studies involved or no ethical statement for the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}